» Articles » PMID: 35172883

Change of Hypothalamic Adult Neurogenesis in Mice by Chronic Treatment of Fluoxetine

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2022 Feb 17
PMID 35172883
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: More than half of patients with depression display eating disorders, such as bulimia nervosa and anorexia nervosa. Feeding centers are located in the hypothalamus, and hypothalamic adult neurogenesis has an important role in feeding and energy balance. Antidepressants, which can regulate adult neurogenesis in the hippocampus, olfactory bulb, and neocortex, are used for eating disorders, but it is unclear whether antidepressants change hypothalamic adult neurogenesis. In this study, we used immunohistological analysis to assess effects of the antidepressant fluoxetine (FLX) on hypothalamic adult neurogenesis of adult mice.

Results: Expressions of the proliferating cell marker, Ki67, and the neural stem cell marker, nestin, were significantly decreased in the hypothalamus by FLX. As regard to postmitotic cells, the number of the neural marker, NeuN, positive cells was significantly upregulated by FLX, but that of the astrocytic marker, S100B, positive cells was significantly reduced by FLX. The number of the oligodendrocyte marker, Olig2, positive cells was not changed by FLX. Interestingly, FLX treatment did not affect the total number of newly generated cells in the hypothalamus, comparing that in controls. These results suggest that FLX treatment influence hypothalamic adult neurogenesis and shift the balance between the numbers of neurons and astrocytes under studied conditions.

Citing Articles

An analogue of the Prolactin Releasing Peptide reduces obesity and promotes adult neurogenesis.

Jorgensen S, Karnosova A, Mazzaferro S, Rowley O, Chen H, Robbins S EMBO Rep. 2024; 25(1):351-377.

PMID: 38177913 PMC: 10897398. DOI: 10.1038/s44319-023-00016-2.


Serotonergic mediation of the brain-wide neurogenesis: Region-dependent and receptor-type specific roles on neurogenic cellular transformation.

Higuchi Y, Arakawa H Curr Res Neurobiol. 2023; 5:100102.

PMID: 37638344 PMC: 10458724. DOI: 10.1016/j.crneur.2023.100102.

References
1.
Sousa-Ferreira L, Aveleira C, Botelho M, Alvaro A, de Almeida L, Cavadas C . Fluoxetine induces proliferation and inhibits differentiation of hypothalamic neuroprogenitor cells in vitro. PLoS One. 2014; 9(3):e88917. PMC: 3943792. DOI: 10.1371/journal.pone.0088917. View

2.
Ohira K . Injury-induced neurogenesis in the mammalian forebrain. Cell Mol Life Sci. 2010; 68(10):1645-56. PMC: 11115059. DOI: 10.1007/s00018-010-0552-y. View

3.
Obernier K, Alvarez-Buylla A . Neural stem cells: origin, heterogeneity and regulation in the adult mammalian brain. Development. 2019; 146(4). PMC: 6398449. DOI: 10.1242/dev.156059. View

4.
Nakajima H, Uchida K, Yayama T, Kobayashi S, Guerrero A, Furukawa S . Targeted retrograde gene delivery of brain-derived neurotrophic factor suppresses apoptosis of neurons and oligodendroglia after spinal cord injury in rats. Spine (Phila Pa 1976). 2010; 35(5):497-504. DOI: 10.1097/BRS.0b013e3181b8e89b. View

5.
Yoo S, Blackshaw S . Regulation and function of neurogenesis in the adult mammalian hypothalamus. Prog Neurobiol. 2018; 170:53-66. PMC: 6173995. DOI: 10.1016/j.pneurobio.2018.04.001. View